Federal contractor · MEMPHIS, TN

ONCTERNAL THERAPEUTICS, INC.

No contract obligations recorded for ONCTERNAL THERAPEUTICS, INC. in FY2026.

Obligations · FY2026
$0
New awards
0
Sole-source
—
Single offer
—
UEI
Q8LNXWE94TX4
Small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 45KFY2018

Top buying agencies

Obligations in FY2026.

No contract obligations recorded for ONCTERNAL THERAPEUTICS, INC. in FY2026.

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

ONCTERNAL THERAPEUTICS, INC. received $0 in federal assistance in FY2026, on 1 actions (0 new awards).

Assistance · FY2026
$0
New awards
0
Actions
1
Since FY2021
$3.9M

Assistance by fiscal year

  1. 1.2MFY2021
  2. 1MFY2022
  3. 753.7KFY2023
  4. 1.1MFY2024
  5. -131.2KFY2025
  6. 0FY2026

Largest awards

  1. PRECLINICAL DEVELOPMENT OF ONCT-505, AN ANDROGEN RECEPTOR ANTAGONIST AND DEGRADER, AS NEW POTENTIAL THERAPEUTIC FOR KENNEDY'S DISEASE…$1.8M
    93.853 · Extramural Research Programs in the Neurosciences and Neurological Disorders· National Institutes of Health· Project grant· Mar 15, 2023 – Jul 8, 2026· R44NS130806

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.